Navigation Links
First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
Date:1/6/2009

MILAN, Italy, Jan. 6 /PRNewswire-FirstCall/ -- A pancreatic cancer patient has become the first person in Italy to be treated using a new, faster form of radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. The Humanitas Clinic in Milan delivered the faster treatment using RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR).

"We see three major benefits with RapidArc," added Dr. Marta Scorsetti, lead clinician at Humanitas. "The short treatment time -- under two minutes in this case -- decreases the chances of the patient moving during treatment, which helps to improve precision. RapidArc enables us to spare more healthy tissue from receiving unnecessary dose and we believe this additional precision will enable us to increase the dose, which should contribute to a higher cure rate."

With RapidArc, Varian's Clinac(R) medical linear accelerator can target radiation beams at a tumor while rotating continuously around the patient. Conventional intensity modulated radiotherapy (IMRT) treatments are slower and more difficult for radiotherapy radiographers and patients because they target tumors using a complex sequence of fixed beams from multiple angles.

Dr. Scorsetti said, "The patient reacted very well to the new treatment and he was comfortable throughout the two minutes he was on the treatment table. As the overall treatment time was reduced, we will be able to treat more patients and consequently reduce waiting times."

Dr. Scorsetti said pancreatic cancers are not traditional candidates for complex treatments with intensity modulated radiotherapy (IMRT) but the introduction of RapidArc means that such patients as well as prostate and head and neck cancer patients can now receive the most advanced
'/>"/>

SOURCE Varian Medical Systems
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary
2. Board-Certified Bariatric Surgeon, Trace Curry, MD Places First Next-Generation Ethicon Endo-Surgery REALIZE™ Adjustable Gastric Band-C in Ohio
3. Robbins & Myers Revises Schedule for Release of First Quarter Fiscal 2009 Financial Results
4. MD Goes HD: Phoenix Doctor Is First to Use New High-Definition Television Production Vehicle to Help Educate and Teach From the Operating Room.
5. First Nationwide Folic Acid Survey of Spanish-Speaking Women Finds Most Are Missing Benefits, March of Dimes Says
6. Central Control is First Louisiana-Based Organization to Deploy Voice-Assisted Care
7. Universal Music Enterprises (UMe) and Body By Jake Global Create the Worlds First Digital Fitness Music Label
8. Supple, Hi-Flex Cable from Cicoil Makes First Disposable Hearing Aid Possible
9. YWCA Survey Reveals Women Want a Modern First Lady
10. Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller
11. Breathing life into injured lungs: World-first technique will expand lung donor organ pool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)... Eva,s Village, ( http://www.EvasVillag...rity, Seeks Buyers for 35mm Michael Jackson Film P... Paterson, NJ (PRWEB) July 3, 20..., a non-profit New Jersey anti-poverty charity, se...print of Michael Jackson,s "Thriller" mu...
(Date:7/3/2009)... Julian Whitaker, MD, a founder of the ...ert on searchjointpain.com, a new informational We...conditions and solutions. , ...aker, MD, a founder of the alternative health move...com, a new informational Web site devoted to all a...
(Date:7/2/2009)...uly 2 Recent news repor...edentials and ensuring that physicians meet high s...ng to the American Board of Medical Specialties (A...Boards in their efforts to develop and implement e...uation and certification of physician specialists....
(Date:7/2/2009)...IA, July 2 A new analys...100,000 women between the ages of 0 to 84 from 200...estimates issued by the Ministry of Health, with t...oungest group studied (ages 25 to 44). , , The ...es that track major breast surgeries rather than o...
Breaking Medicine News(10 mins):Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 3
...yndrome (PTSD) is a disabiling anxiety disorder, w...later during World War I, as soldier's heart and s... even those who are affected by cancer and their f...According to foodconsumer.org, PTSD affects about ...
...has been filed against the anti-HIV drug, Combivir...aceutical company //. The Manipur Network of Posit... Living with HIV/AIDS have lodged the complaint at...formulation is a combination of two essential anti...
...reated to deal with crimes committed by drug addic...e years, before such courts would be started all a...in Glasgow in 2001 and Fife in 2002. These will un...ish Executive’s. This decision was announced yes...
...cing new HIV infections in the southern states thr...e as a roadmap for other countries, says an Indo-C...ons, mostly based on guesswork, that India's AIDS ...d done in southern Africa - but we now have direct...
Other Medicine News:Health News:New Therapy For Treating Post-Traumatic Stress Syndrome 2Health News:India Can Become A Role Model In Combating HIV Infections 2
(Date:6/30/2009)... June 30 Calixa Therapeutics Inc. ...al trial of CXA-101 in patients with complicated u...pectrum, parenteral cephalosporin antibiotic with ...t Pseudomonas aeruginosa , including drug resista... potential treatment for serious bacterial infecti...
(Date:6/29/2009)... Minn., June 29 Pionee...veness of deep brain stimulation (DBS) in hard...r (OCD) and Tourette,s syndrome are underway at mu... to a review in the June 2009 issue of Mayo C...long been seen as valuable for controlling movemen...
(Date:6/29/2009)...MPTON, England, June 29 Vantia The...eloping novel, small molecule drugs,targeting lar...e results from,a Phase IIa clinical trial of its ...The trial showed that oral VA106483 was successful...uretic effect in patients, as determined by,incre...
(Date:6/28/2009)...NHAM, England and TOKYO, June 29 ,... Companies , Sosei Group Corporation ("Sose...c ("Vectura"; LSE: VEC) announce the commencement ...VA237, a once-daily, long-acting muscarinic,antag...ive pulmonary disease,(COPD). NVA237 is a dry pow...
Breaking Medicine Technology:Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4Vion Pharmaceuticals Reports 2009 First Quarter Results 45405 1Vion Pharmaceuticals Reports 2009 First Quarter Results 45405 2Vion Pharmaceuticals Reports 2009 First Quarter Results 45405 3Vion Pharmaceuticals Reports 2009 First Quarter Results 45405 4Vion Pharmaceuticals Reports 2009 First Quarter Results 45405 5The Healthcare Scoop Seeks Women 26apos 3Bs Health Osteoporosis Arthritis Stories 45404 1The Healthcare Scoop Seeks Women 26apos 3Bs Health Osteoporosis Arthritis Stories 45404 2The Healthcare Scoop Seeks Women 26apos 3Bs Health Osteoporosis Arthritis Stories 45404 3The Healthcare Scoop Seeks Women 26apos 3Bs Health Osteoporosis Arthritis Stories 45404 4Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 1Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 2Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 3Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 4Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 5Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 6Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 7Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 12041 8Sinobiopharma Announces SFDA Approval of Anti Hypertension Drug Perindopril 12038 1Sinobiopharma Announces SFDA Approval of Anti Hypertension Drug Perindopril 12038 2
...ed at Least 75 Percent Improvement in Psoriasis,Si...g Groups, More,Than Half Achieved 90 Percent Impro...e-FirstCall/ -- New,Phase II study results show Ab... psoriasis symptoms significantly in the majority,...atients with,moderate to severe psoriasis achieved...
... 4th May 2007 - CeNeS Pharmaceuticals plc,(LSE: CE... notes,the publication of an independent study in ... Phase II NMDA antagonist, CNS 5161. CeNeS,is deve...pathic,pain. The independent study builds on the w...1. , In the study reported in ,Synapse, Dr Anat B...
Other Medicine Technology:Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 3Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 4Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
This compression garment can be used immediatlely following Abdominoplasty, Tram Flap, Abdominal Liposuction, Lipoplasty, Suction Lipectomy, Stomach Liposuction, Liposculpture and Tummy Tuck procedur
CDIs original garments with our exclusive Wonderfabric™.
Below Knee Girdle, High Waist
Short Girdle, High Waist, Mid-thigh
Medicine Products: